CompoSecure’s (CMPO) “Buy” Rating Reiterated at Benchmark

Benchmark reaffirmed their buy rating on shares of CompoSecure (NASDAQ:CMPO) in a report released on Tuesday morning,Benzinga reports. They currently have a $17.00 target price on the stock.

CMPO has been the topic of several other research reports. Needham & Company LLC restated a “buy” rating and set a $16.00 price objective on shares of CompoSecure in a report on Monday. Bank of America upped their price target on shares of CompoSecure from $9.00 to $10.00 and gave the company a “buy” rating in a research note on Thursday, August 8th. Compass Point lifted their price objective on shares of CompoSecure from $11.50 to $14.50 and gave the stock a “buy” rating in a research note on Tuesday, August 20th. JPMorgan Chase & Co. upped their target price on CompoSecure from $8.00 to $12.00 and gave the company a “neutral” rating in a research report on Tuesday, August 20th. Finally, Lake Street Capital lifted their price target on CompoSecure from $14.00 to $18.00 and gave the stock a “buy” rating in a research report on Wednesday, October 2nd. One investment analyst has rated the stock with a hold rating and six have assigned a buy rating to the company. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $15.79.

CompoSecure Stock Up 1.5 %

Shares of CMPO opened at $13.94 on Tuesday. The company has a 50 day moving average of $14.02 and a two-hundred day moving average of $10.06. CompoSecure has a twelve month low of $4.61 and a twelve month high of $16.14. The company has a market cap of $1.23 billion, a price-to-earnings ratio of -31.68, a price-to-earnings-growth ratio of 1.13 and a beta of 0.76.

CompoSecure (NASDAQ:CMPO) last posted its quarterly earnings data on Friday, November 8th. The company reported $0.27 earnings per share for the quarter, missing analysts’ consensus estimates of $0.29 by ($0.02). CompoSecure had a negative return on equity of 14.87% and a negative net margin of 5.63%. The business had revenue of $107.14 million during the quarter, compared to analyst estimates of $105.11 million. During the same period in the previous year, the business earned $0.24 EPS. On average, sell-side analysts expect that CompoSecure will post 1.02 EPS for the current year.

Insider Buying and Selling at CompoSecure

In other news, Director Michele Logan sold 10,017,983 shares of the business’s stock in a transaction dated Tuesday, September 17th. The stock was sold at an average price of $7.55, for a total value of $75,635,771.65. Following the completion of the transaction, the director now owns 2,043,320 shares of the company’s stock, valued at $15,427,066. The trade was a 83.06 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, CEO Jonathan Wilk sold 618,014 shares of the company’s stock in a transaction dated Tuesday, September 17th. The stock was sold at an average price of $7.55, for a total value of $4,666,005.70. Following the completion of the sale, the chief executive officer now owns 618,013 shares in the company, valued at $4,665,998.15. The trade was a 50.00 % decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders have sold 10,641,727 shares of company stock valued at $80,370,824. 74.99% of the stock is owned by insiders.

Hedge Funds Weigh In On CompoSecure

Several institutional investors have recently made changes to their positions in the company. Woodson Capital Management LP purchased a new stake in CompoSecure during the third quarter worth $10,795,000. Progeny 3 Inc. purchased a new stake in shares of CompoSecure during the 3rd quarter worth about $5,243,000. Pacific Ridge Capital Partners LLC boosted its stake in shares of CompoSecure by 146.9% during the 2nd quarter. Pacific Ridge Capital Partners LLC now owns 486,462 shares of the company’s stock worth $3,308,000 after acquiring an additional 289,451 shares in the last quarter. Rice Hall James & Associates LLC acquired a new stake in shares of CompoSecure during the 3rd quarter valued at about $3,766,000. Finally, Boston Partners increased its stake in shares of CompoSecure by 40.8% in the 1st quarter. Boston Partners now owns 557,136 shares of the company’s stock valued at $4,028,000 after purchasing an additional 161,333 shares in the last quarter. 37.56% of the stock is owned by hedge funds and other institutional investors.

About CompoSecure

CompoSecure, Inc manufactures and designs metal, composite, and proprietary financial transaction cards in the United States and internationally. Its primary metal form factors include embedded, metal veneer lite, metal veneer, and full metal products. The company also offers Arculus Cold Storage Wallet, a three-factor authentication solution, which supports specific digital assets, including Bitcoin, Ethereum, non-fungible tokens and others.